Oncology conference coverage
20-10-2015 | Lung cancer | News | Article
Early trial results in lung cancer
Results from early phase trials investigating different therapeutic agents in lung cancer patients were presented during the third Presidential Session at the European Cancer Congress in Vienna, Austria. Here we summarise two studies reported at the session.
16-10-2015 | Melanoma | News | Article
PD-1 blockade in advanced melanoma
The safety and efficacy of the programmed death 1 inhibitors nivolumab and pembrolizumab in patients with melanoma formed a key part of the Melanoma and Skin Cancer proffered paper session at the European Cancer Congress in Vienna, Austria. This report summarises two presentations from the session.
02-06-2015 | Oncology | News | Article
CheckMate for nivolumab in untreated melanoma, squamous NSCLC
Two phase III trials published in The New England Journal of Medicine support the use of nivolumab in patients with treatment-naïve metastatic melanoma and in those with squamous non-small-cell lung cancer who have failed first-line chemotherapy.
N Engl J Med 2015; Advance online publication
08-06-2015 | Oncology | News | Article
Ibrutinib shows promise in CLL/SLL
The addition of ibrutinib to bendamustine and rituximab significantly prolongs progression-free survival in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma, according to the HELIOS trial.
Mansoor Raza Mirza/© Lynda Williams, lung_cancer2, chess